Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies.
about
Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells.Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application.Microenvironment and pathogenesis of epithelial ovarian cancerPrognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinomaImpact of vessel maturation on antiangiogenic therapy in ovarian cancer.Angiogenesis-related pathways in the pathogenesis of ovarian cancerHigh VEGFR1/2 expression levels are predictors of poor survival in patients with cervical cancer.Pazopanib: an antiangiogenic drug in perspective.Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.Targeted agents in ovarian cancer.Anti-angiogenic drugs currently in Phase II clinical trials for gynecological cancer treatment.Ovarian cancer biology and immunotherapy.Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives.Environmentally relevant concentration of arsenic trioxide and humic acid promoted tumor progression of human cervical cancer cells: In vivo and in vitro studies.Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.Inhibition of AGS Cancer Cell Proliferation following siRNA-Mediated Downregulation of VEGFR2.Inhibition of VEGF: a novel mechanism to control angiogenesis by Withania somnifera's key metabolite Withaferin A.The siRNA-Mediated Down-Regulation of Vascular Endothelial Growth Factor Receptor1What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies?Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.Reduction in the mRNA expression of sVEGFR1 and sVEGFR2 is associated with the selection of dominant follicle in cows.Expression of HSP90AA1/HSPA8 in hepatocellular carcinoma patients with depression.Angiogenesis Inhibitors for the Treatment of Ovarian Cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials.
P2860
Q34210916-B2D9DF79-CE7D-43F4-8684-B416680855FCQ35233993-D39EDC29-AA2D-4113-AE37-A4B3541256EBQ35419057-7F1E2372-6A1A-4CD5-8F5D-D37CB620783AQ36103829-8F61BD37-2851-4359-9234-FE906F4C1E71Q36593708-27AFD179-E359-45A7-A867-A6DBEEEC1CCAQ37139109-86EA91D2-4AFF-4C75-A9CF-D3AA28471DA3Q37582642-A538936C-9BBD-4D77-B6C2-B4C86379D44FQ37630567-32BBA5ED-5767-4183-9891-BA897AD944B5Q37668050-CF3D0861-199C-4F15-B38D-839F0DD3A5AAQ37795802-A83B56EF-E1E5-4C26-91A9-B9143C6CEE7AQ38115596-848B8FA3-9F15-41FA-A40C-B6BCC3554F93Q38218761-046E8B1B-5ECE-4108-ADE8-34F93B6C2FE4Q38845930-46E1CDF9-D465-490E-A4D9-4B701D2FA8D0Q38904945-4EFB12B4-588F-425B-8BF5-D9AC7C224368Q39426973-43978A05-AACB-48DE-BC41-A7FBB3CD23A7Q41015064-4050CD33-696A-43FE-9F58-2CBCD7C99259Q41692367-620F72A8-B09A-42C2-9204-FC107EA8EDD6Q41820460-6B10C7A9-BC19-4524-8292-5D1E1E5BDDE4Q44827940-534C8322-AB7A-4A24-93FB-1CF9A568F98EQ47141265-0CE38C2C-EA17-42B3-AE79-CCF4A085A795Q51482443-DCF4DBC4-BA47-4BE9-B184-9F1578049341Q55134101-148D33D9-4B11-4B8C-A288-BF432E301C32Q55217694-1477A5E4-3E33-44FB-989C-B434A3B4BEB2
P2860
Vascular endothelial growth factor (VEGF) pathway as a therapeutic target in gynecologic malignancies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Vascular endothelial growth fa ...... t in gynecologic malignancies.
@ast
Vascular endothelial growth fa ...... t in gynecologic malignancies.
@en
type
label
Vascular endothelial growth fa ...... t in gynecologic malignancies.
@ast
Vascular endothelial growth fa ...... t in gynecologic malignancies.
@en
prefLabel
Vascular endothelial growth fa ...... t in gynecologic malignancies.
@ast
Vascular endothelial growth fa ...... t in gynecologic malignancies.
@en
P2860
P1433
P1476
Vascular endothelial growth fa ...... t in gynecologic malignancies.
@en
P2093
Anil K Sood
P2860
P304
P356
10.1016/J.YGYNO.2006.10.062
P407
P577
2007-03-01T00:00:00Z